Who is sponsoring PULSAR?

PULSAR is sponsored by Centre Oscar Lambret.

What condition does PULSAR study?

PULSAR studies Metastatic Colorectal Cancer.

What drugs are being tested in PULSAR?

Interventions: Aflibercept-FOLFIRI.

What is the status of PULSAR?

PULSAR is currently TERMINATED.

Last reviewed 2021-10-19 · How we verify

A Phase 2 Study of Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US. (PULSAR)

NCT02173990 Phase 2 TERMINATED

The PULSAR trial is an international, investigator-initiated, single arm open-label phase II study. The aim of this study is to measure the clinical activity of the combination FOLFIRI-aflibercept in an homogeneous group of patients with metastatic colorectal cancer, and treated with a FOLFIRI-aflibercept regimen as first line treatment.

Details

Lead sponsor	Centre Oscar Lambret
Phase	Phase 2
Status	TERMINATED
Enrolment	40
Start date	2014-07
Completion	2019-10-22

Conditions

Metastatic Colorectal Cancer

Interventions

Aflibercept-FOLFIRI

Primary outcomes

Progression-Free Rate will be assessed according to RECIST 1.1 with central radiological review. — At 10-month

Countries

France